Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The fight against cancer has seen remarkable advancements, largely driven by breakthroughs in medicinal chemistry and the development of targeted therapies. Lenvatinib, a potent multi-kinase inhibitor, stands as a testament to these advancements, offering hope to patients with various difficult-to-treat cancers. Behind the efficacy of such drugs lies a complex process of chemical synthesis, where specific intermediates are indispensable. This article delves into the chemical journey of Lenvatinib and the critical role of its key intermediate, N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea (CAS 796848-79-8).
Understanding Lenvatinib and its Mechanism
Lenvatinib is an orally administered small molecule that targets multiple receptor tyrosine kinases (RTKs) involved in tumor proliferation and angiogenesis. By inhibiting pathways such as VEGFR, FGFR, PDGFR, KIT, and RET, it effectively halts tumor growth and blood vessel formation. The development of such a targeted therapy requires sophisticated organic synthesis, where each step and intermediate must meet stringent quality and purity standards.
N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea: A Critical Building Block
N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea, a meticulously synthesized organic compound, serves as a foundational intermediate in the multi-step synthesis of Lenvatinib. Its chemical structure, characterized by a chlorinated phenyl ring and a cyclopropylurea moiety, is specifically designed to be incorporated into the larger, more complex Lenvatinib molecule. The consistent availability of this intermediate with high purity (typically ≥98.0%) from reliable manufacturers and suppliers is crucial for efficient and cost-effective Lenvatinib production.
The Importance of Sourcing This Intermediate
Pharmaceutical companies and research institutions looking to purchase N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea must prioritize sourcing from reputable providers. When you buy this critical component, consider:
NINGBO INNO PHARMCHEM CO.,LTD. as Your Partner
As a dedicated pharmaceutical intermediate supplier, NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing high-quality N-(2-Chloro-4-hydroxyphenyl)-N'-Cyclopropylurea. We understand the critical requirements of the pharmaceutical industry and are committed to delivering products that meet global standards. Our role as a trusted manufacturer ensures that you receive an intermediate that contributes to the successful synthesis of advanced therapies like Lenvatinib.
By choosing a reliable manufacturer and supplier, you secure a vital element in the intricate chemistry of cancer treatment, supporting the development and accessibility of life-saving medications.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
